Vimarsana
Biggest News Aggregation in the World

Page 29 - Cardiovascular Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cardiovascular Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cardiovascular Sciences Today - Breaking & Trending Today

Treating heart attack before it happens: It may not be science fiction - Vimarsana News

Treating heart attack before it happens: It may not be science fiction

Researchers discovered a mechanism that allows them to treat heart tissue in mice, before a heart attack, in a way that provides protection months later.

Peptide Potential for Managing Obesity-related Conditions - Vimarsana News

Peptide Potential for Managing Obesity-related Conditions

Researchers at the University of Birmingham have investigated a naturally occurring peptide (small protein) called PEPITEM as a potential approach to reducing the risk of type 2 diabetes and other obesity-related diseases such as hepatic steatosis (fatty liver). Click to read more...

LIVE-HCM Study: Insights on Hypertrophic Cardiomyopathy Management - Vimarsana News

LIVE-HCM Study: Insights on Hypertrophic Cardiomyopathy Management

Until recently, patients with HCM were advised to avoid vigorous exercise. An observational trial evaluated the health impacts of activities such as running,

Source: yale.edu
Eating too much salt can cause significant changes to your behavior - Vimarsana News

Eating too much salt can cause significant changes to your behavior

You know that salt is bad for your heart and blood pressure, but you probably don't know that it can also change your behavior. How?

Source: jpost.com
Comparison of diuretics shows no difference in heart failure survival - Vimarsana News

Comparison of diuretics shows no difference in heart failure survival

Two drugs widely used to treat adults with heart failure – furosemide and torsemide – showed no difference in their ability to improve patient survival when compared, according to findings from a clinical trial supported by the National Institutes of Health. The trial, one of the largest to date studying routine medications in heart failure,Two drugs widely used to treat adults with heart failure – furosemide and torsemide – showed no difference in their ability to improve patient survival when compared, according to findings from a clinical trial supported by the National Institutes o...